These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 7223593

  • 1. Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failure.
    Feldman RC, Ball RM, Winchester MA, Jaillon P, Kates RE, Harrison DC.
    Am Heart J; 1981 May; 101(5):534-40. PubMed ID: 7223593
    [Abstract] [Full Text] [Related]

  • 2. Attenuation of prazosin effect on cardiac output in chronic heart failure.
    Arnold SB, Williams RL, Ports TA, Baughman RA, Benet LZ, Parmley WW, Chatterjee K.
    Ann Intern Med; 1979 Sep; 91(3):345-9. PubMed ID: 475164
    [Abstract] [Full Text] [Related]

  • 3. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
    Desch CE, Magorien RD, Triffon DW, Blanford MF, Unverferth DV, Leier CV.
    Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512
    [Abstract] [Full Text] [Related]

  • 4. The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure.
    Harper RW, Claxton H, Middlebrook K, Anderson S, Pitt A.
    Med J Aust; 1980 Jul 26; 2(SP1):36-8. PubMed ID: 7421721
    [No Abstract] [Full Text] [Related]

  • 5. Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure.
    Bertel O, Burkart F, Bühler FR.
    Am Heart J; 1981 May 26; 101(5):529-33. PubMed ID: 7223592
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the vasodilator prazosin and the selective beta1 agonist prenalterol on rest and exercise haemodynamics in CHF.
    Hutton I, Tweddel AC, Bastian BC, Murray RG.
    Acta Med Scand Suppl; 1981 May 26; 652():163-8. PubMed ID: 6120615
    [No Abstract] [Full Text] [Related]

  • 7. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
    Miller RR, Awan NA, Maxwell KS, Mason DT.
    N Engl J Med; 1977 Aug 11; 297(6):303-7. PubMed ID: 889599
    [Abstract] [Full Text] [Related]

  • 8. [Sustained and beneficial hemodynamic effects of prazosin in cardiac insufficiency].
    Harrison DC, Feldman RC, Ball RM.
    Cardiology; 1980 Aug 11; 66 Suppl 2():162-8. PubMed ID: 6456814
    [No Abstract] [Full Text] [Related]

  • 9. Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure.
    Mehta J, Iacona M, Feldman RL, Pepine CJ, Conti CR.
    Am J Cardiol; 1978 May 01; 41(5):925-30. PubMed ID: 645603
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.
    Awan NA, Miller RR, DeMaria AN, Maxwell KS, Neumann A, Mason DT.
    Circulation; 1977 Sep 01; 56(3):346-54. PubMed ID: 884789
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
    Awan NA, Needham KE, Evenson MK, Amsterdam EE, Mason DT.
    Am J Med; 1981 Jul 01; 71(1):153-60. PubMed ID: 7246573
    [Abstract] [Full Text] [Related]

  • 12. Haemodynamic effects of prazosin in CHF.
    Reuben SR, Kuan P, Gale EV, Wilde PM.
    Acta Med Scand Suppl; 1981 Jul 01; 652():145-8. PubMed ID: 6949460
    [Abstract] [Full Text] [Related]

  • 13. [Prazosin in the treatment of chronic cardiac insufficiency].
    Champoud O, Cribier A, Letac B.
    Ann Med Interne (Paris); 1985 Jul 01; 136(3):261-5. PubMed ID: 2862824
    [Abstract] [Full Text] [Related]

  • 14. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.
    Elkayam U, Mathur M, Frishman W, LeJemtel T, Strom J, Sonnenblick EH.
    Clin Pharmacol Ther; 1981 Jul 01; 30(1):23-30. PubMed ID: 7237894
    [Abstract] [Full Text] [Related]

  • 15. Non-invasive radiocardiographic assessment of the effects of prazosin in congestive heart failure.
    Nakajima H, Yui Y, Kawashita K, Yoshida A, Kawai C.
    Jpn Circ J; 1982 May 01; 46(5):468-72. PubMed ID: 7077811
    [Abstract] [Full Text] [Related]

  • 16. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
    Magorien RD, Triffon DW, Desch CE, Bay WH, Unverferth DV, Leier CV.
    Ann Intern Med; 1981 Jul 01; 95(1):5-13. PubMed ID: 7247126
    [Abstract] [Full Text] [Related]

  • 17. Effect of prostacyclin and prazosin in the treatment of congestive heart failure; with special reference to the sympathetic nervous system.
    Yui Y, Sakurai T, Nakajima H, Kawai C.
    Jpn Circ J; 1984 Apr 01; 48(4):365-72. PubMed ID: 6371282
    [Abstract] [Full Text] [Related]

  • 18. Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.
    Elkayam U, Roth A, Henriquez B, Weber L, Tonnemacher D, Rahimtoola SH.
    Am J Cardiol; 1985 Sep 15; 56(8):555-9. PubMed ID: 3929585
    [Abstract] [Full Text] [Related]

  • 19. Acute and chronic haemodynamic effects of prazosin in left ventricular failure.
    Stein L, Foster PR, Friedman AW, Statza J, McHenry PL.
    Br Heart J; 1981 Feb 15; 45(2):186-92. PubMed ID: 7459177
    [Abstract] [Full Text] [Related]

  • 20. Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure.
    Elkayam U, Lejemtel TH, Mathur M, Ribner HS, Frishman WH, Strom J, Sonnenblick EH.
    Am J Cardiol; 1979 Sep 15; 44(3):540-5. PubMed ID: 474434
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.